Treatment of disseminated renal cell cancer with combinations of interleukin-2, lymphokine-activated killer cells, and alpha-interferon. 1992

G Stoter, and S H Goey, and D Batchelor, and A M Eggermont, and C Lamers, and J W Gratama, and R L Bolhuis
Department of Medical Oncology, Rotterdam Cancer Institute, Dr. Daniel den Hoed Kliniek, The Netherlands.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D015979 Killer Cells, Lymphokine-Activated Cytolytic lymphocytes with the unique capacity of killing natural killer (NK)-resistant fresh tumor cells. They are INTERLEUKIN-2-activated NK cells that have no MAJOR HISTOCOMPATIBILITY COMPLEX restriction or need for antigen stimulation. LAK cells are used for ADOPTIVE IMMUNOTHERAPY in cancer patients. LAK Cells,Lymphokine-Activated Killer Cells,Cell, LAK,Cell, Lymphokine-Activated Killer,Cells, LAK,Cells, Lymphokine-Activated Killer,Killer Cell, Lymphokine-Activated,Killer Cells, Lymphokine Activated,LAK Cell,Lymphokine Activated Killer Cells,Lymphokine-Activated Killer Cell

Related Publications

G Stoter, and S H Goey, and D Batchelor, and A M Eggermont, and C Lamers, and J W Gratama, and R L Bolhuis
October 1987, The New England journal of medicine,
G Stoter, and S H Goey, and D Batchelor, and A M Eggermont, and C Lamers, and J W Gratama, and R L Bolhuis
June 1988, The New England journal of medicine,
G Stoter, and S H Goey, and D Batchelor, and A M Eggermont, and C Lamers, and J W Gratama, and R L Bolhuis
June 1988, Leukemia,
G Stoter, and S H Goey, and D Batchelor, and A M Eggermont, and C Lamers, and J W Gratama, and R L Bolhuis
April 1989, Mayo Clinic proceedings,
G Stoter, and S H Goey, and D Batchelor, and A M Eggermont, and C Lamers, and J W Gratama, and R L Bolhuis
September 1985, Surgery,
G Stoter, and S H Goey, and D Batchelor, and A M Eggermont, and C Lamers, and J W Gratama, and R L Bolhuis
June 1995, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
G Stoter, and S H Goey, and D Batchelor, and A M Eggermont, and C Lamers, and J W Gratama, and R L Bolhuis
January 1989, Acta chirurgica Scandinavica. Supplementum,
G Stoter, and S H Goey, and D Batchelor, and A M Eggermont, and C Lamers, and J W Gratama, and R L Bolhuis
January 1994, British journal of urology,
G Stoter, and S H Goey, and D Batchelor, and A M Eggermont, and C Lamers, and J W Gratama, and R L Bolhuis
April 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
G Stoter, and S H Goey, and D Batchelor, and A M Eggermont, and C Lamers, and J W Gratama, and R L Bolhuis
September 1987, Annals of internal medicine,
Copied contents to your clipboard!